Predicting when you can stop kidney dialysis
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies whether a blood test called delta C-cistatin can help doctors predict when patients can safely stop continuous kidney dialysis after acute kidney injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have acute kidney injury (sudden kidney failure).
- You need continuous dialysis as decided by your kidney doctor.
- You agree to take part and sign a consent form.
- You have not been on any type of dialysis in the past 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different ways of doing dialysis in intensive care to see which works best for helping kidneys recover. It might help you if you are in the ICU with sudden kidney injury.
This trial compares the usual dose of continuous dialysis with a lower dose to see if a lower dose is just as safe and effective for critically ill patients with sudden kidney failure.
This trial tests a special device that filters parts of the blood to calm inflammation in people with severe acute kidney injury in the ICU. It may help improve recovery and reduce complications by “deactivating” certain immune cells.
This study tests whether a simple scoring tool can help doctors predict which ICU patients may develop kidney problems. It may help identify patients at risk early so they can receive closer monitoring.
This study uses a risk score and blood tests to predict which hospitalized patients might develop acute kidney injury (sudden kidney damage). If you are at high risk, researchers will follow you closely to see if early detection can help prevent serious kidney problems.
This study compares two different doses of continuous kidney replacement therapy (CRRT, a type of dialysis) for patients in the intensive care unit with acute kidney injury. It aims to find out if a lower dose is as safe and effective as the standard dose.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.